Allakos Newsroom

JMP Securities Maintains Allakos(ALLK.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsDec 17 00:33 ET

Promising Potential of Allakos's AK006 Drives Buy Rating Amidst Market Interest in Chronic Spontaneous Urticaria

TipRanksDec 17 00:30 ET

A Quick Look at Today's Ratings for Allakos(ALLK.US), With a Forecast Between $1 to $7

Moomoo NewsNov 8 08:14 ET

Cautious Hold Rating for Allakos Amid Uncertain Clinical and Financial Outlook

TipRanksNov 8 02:31 ET

Piper Sandler Maintains Allakos(ALLK.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 7 07:31 ET

Barclays Maintains Allakos(ALLK.US) With Sell Rating, Maintains Target Price $1

Moomoo NewsNov 7 03:34 ET

TD Cowen Maintains Allakos(ALLK.US) With Hold Rating

Moomoo NewsNov 7 02:31 ET

Allakos (ALLK) Gets a Hold From TD Cowen

TipRanksNov 7 00:29 ET

Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)

TipRanksOct 14 02:43 ET

TD Cowen Maintains Allakos(ALLK.US) With Hold Rating

Moomoo NewsOct 11 08:34 ET

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Allakos (ALLK) and Tempest Therapeutics (TPST)

TipRanksOct 11 07:35 ET

LifeSci Capital Maintains Allakos(ALLK.US) With Hold Rating

Moomoo NewsOct 11 07:31 ET

JMP Securities Maintains Allakos(ALLK.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsSep 26 00:32 ET

JMP Securities Maintains Allakos(ALLK.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsSep 25 20:32 ET

Maintaining Hold on Allakos: Weighing AK006 Promise Against Clinical Setbacks

TipRanksAug 9 06:04 ET

Allakos's Promising Drug and Financial Health Garner a Buy Rating

TipRanksAug 8 01:22 ET

TD Cowen Sticks to Its Hold Rating for Allakos (ALLK)

TipRanksAug 7 19:58 ET

Allakos Analyst Ratings

BenzingaJul 18 09:20 ET

Allakos Analyst Ratings

BenzingaJun 26 12:04 ET

Allakos Analyst Ratings

BenzingaJun 20 13:21 ET